New hope for lymphoma patients as First-in-Human drug trial begins
Disease control
Not yet recruiting
This is the first study in people to test a new drug called TORL-5-700 for B-cell Non-Hodgkin Lymphoma that has come back or not responded to other treatments. The main goals are to find a safe dose and see if the drug can shrink tumors, both on its own and when combined with oth…
Phase: PHASE1, PHASE2 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC